HCTINasdaqServices-Computer Integrated Systems DesignFiscal year ends December 31

Healthcare Triangle, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.36−0.03 (-8.44%)

Close on Oct 19, 2026

Market cap: $1.02M
P/E (TTM): –
Dividend yield: –

Healthcare Triangle, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q2 2026 2026-06-30	TTM Q1 2026 2026-03-31	TTM FY 2025 2025-12-31	TTM Q3 2025 2025-09-30	TTM Q2 2025 2025-06-30	TTM Q1 2025 2025-03-31	TTM FY 2024 2024-12-31	TTM Q3 2024 2024-09-30	TTM Q2 2024 2024-06-30	TTM Q1 2024 2024-03-31	TTM FY 2023 2023-12-31	TTM Q3 2023 2023-09-30	TTM Q2 2023 2023-06-30	TTM Q1 2023 2023-03-31	TTM FY 2022 2022-12-31	TTM Q3 2022 2022-09-30	TTM Q2 2022 2022-06-30	TTM Q1 2022 2022-03-31	TTM FY 2021 2021-12-31	TTM Q3 2021 2021-09-30	TTM Q2 2021 2021-06-30	TTM FY 2020 2020-12-31
Revenue	26	20	14	13	12	11	12	17	22	27	33	37	42	45	46	44	40	38	35	35	34	31
Cost of Revenue	20	16	12	11	10	9.09	8.81	12	17	21	26	30	33	35	35	32	29	27	25	24	24	23
Gross Profit	1,239	1,237	1,235	2,140	1,070	1,070	1,070	1,072	1,073	1,075	1,070	7.06	8.78	9.99	11	12	11	11	11	11	9.93	8.59
Research & Development	0.47	0.48	0.54	–	–	–	–	0.61	0.49	0.39	0.80	5.65	7.07	7.61	8.14	4.67	5.40	5.57	5.26	4.05	2.39	1.74
Selling, General & Admin	18	14	10	7.66	5.93	5.67	6.15	6.88	7.97	9.07	10	–	–	–	–	–	–	–	–	–	–	–
Selling & Marketing	4.59	4.49	3.08	2.41	1.68	1.69	2.20	2.59	3.40	3.79	4.67	–	–	–	–	–	–	–	–	–	–	–
General & Administrative	13	9.36	7.34	5.26	4.25	3.97	3.95	4.29	4.57	5.28	5.73	5.84	5.96	5.80	5.52	5.66	4.93	4.53	4.44	3.17	3.00	2.44
Advertising Expenses	–	–	1.70	1.01	0.43	0.34	0.61	0.86	1.89	2.77	0.53	5.49	6.20	6.83	1.16	5.43	4.94	4.09	4.76	5.23	4.37	2.42
Operating Expenses	20	16	12	7.54	6.22	6.65	7.64	9.79	11	12	14	24	27	28	28	21	20	18	16	–	–	–
Operating Income	-15	-12	-9.79	-5.85	-4.42	-4.44	-4.75	-5.63	-5.98	-6.20	-7.70	-17	-18	-18	-16	-8.99	-8.52	-6.61	-5.36	-1.52	0.44	1.18
Interest Expense	0.42	0.34	0.57	–	–	–	–	1.27	0.94	0.88	0.97	-0.58	-0.11	0.13	0.21	0.22	0.38	0.49	0.57	0.53	0.31	0.08
Other Non-Operating Income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.71	-0.49	-0.57	0.98	1.20	1.43
Pretax Income	-17	-14	-9.48	-6.32	-5.66	-5.80	-5.96	-6.29	-6.98	-7.25	-8.65	-16	-16	-15	-14	-8.12	-7.81	-7.10	-5.93	-0.54	1.64	2.61
Income Tax Expense	–	–	–	–	–	–	0.01	0.02	0.02	0.02	0.04	0.48	0.52	0.51	0.51	0.08	0.04	0.04	0.02	0.09	0.14	0.26
Income from Continuing Operations	13	–	9.79	–	–	–	–	–	–	–	-0.04	-1.18	-1.90	-1.74	-0.51	-8.99	-8.52	-6.61	-5.36	-0.01	1.96	2.69
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	–	-0.40	-3.65	-4.05	-2.66	-1.39	-8.20	-7.85	-7.14	-5.95	1.00	3.13	2.35
Net Income	-17	-14	-9.48	-6.32	-5.66	-5.81	-5.97	-6.30	-6.99	-7.27	-8.69	-17	-17	-16	-14	-8.20	-7.85	-7.14	-5.95	-0.63	1.51	2.35
Net Income to Common	-4.13	-1.35	9.43	0.19	-0.47	-0.61	5.97	-7.08	-10	-11	-8.69	-19	-19	-18	-14	-8.20	-7.85	-7.15	-5.95	-0.63	1.51	2.35
EPS (Basic)(per share)	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-60.36	-61.37	-56.39	-50.30	-4.91	13.51	20.92
EPS (Diluted)(per share)	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-60.36	-61.37	-56.39	-50.30	-4.91	13.51	20.92
Shares Outstanding (Basic, Weighted)(shares)	–	–	–	–	–	–	–	0.02	0.02	0.02	0.02	–	–	–	–	0.14	0.13	0.13	0.12	0.12	0.12	0.11
Shares Outstanding (Diluted, Weighted)(shares)	–	–	–	–	–	–	–	0.02	0.02	0.02	0.02	–	–	–	–	0.14	0.13	0.13	0.12	0.12	0.12	0.11
EBITDA	-13	-11	-9.08	-5.92	-4.21	-3.70	-3.86	-5.03	-5.02	-4.97	-6.13	-14	-15	-15	-13	-5.74	-5.96	-4.69	-3.94	-0.69	1.27	1.98
Net Interest Income	-0.31	-0.24	-0.57	-1.32	-1.37	-1.48	-1.21	-0.67	-1.00	-1.06	-0.97	-0.75	-0.39	-0.26	-0.21	-0.22	-0.38	–	-0.57	–	–	–
Provision for Credit Losses	–	–	0.02	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 4824.1%
Operating margin: -57.4%
Net margin: -66.3%
Return on equity, FY2025: –

Financial strength

Current ratio: 0.60
Debt to equity: –
Debt to assets: 23.4%
Cash to current liabilities: 11.9%

Valuation

P/E ratio: –
Price to sales: 0.04
Price to book: –
Dividend yield: –